To guide public health and vaccination strategies, researchers assessed a variety of factors regarding community-acquired pneumonia and its causes.
|Articles|July 8, 2022
News Roundup: July 1 to July 8
Author(s)Miranda Hester
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
Pharmacists Authorized by FDA to Prescribe Paxlovid, With Limitations
According to the agency, this new authority may improve access to patients at high risk for severe COVID-19.
Dulaglutide Effective in Children with Type 2 Diabetes
New research indicates dulaglutide is effective in improving glycemic control in pediatric patients with diabetes.
Acne Treatments and Considering Mental Health
The effect of acne is more than skin deep.
Higher Risk for Uncontrolled Hypertension Found in Black Patients with MS
Hypertension adversely impacts the multiple sclerosis (MS) disease course and is more common among Black Americans.
At Least 105 Million Doses of COVID-19 Vaccine for Fall Ordered by HHS
Purchase follows FDA recommendation to include Omicron component in boosters.
Advertisement
Related to this article
Highlighting the clinical impact of the pharmacy profession, we caught up with pharmacists of various types to get their perspectives on the evolution of pharmacy.
A newly erected Women’s Health Division within NIH will work in tandem with the Office of Research on Women’s Health.
Rita King, CEO of MethodSense, provides her expertise on the integration of AI in medical devices and key developments for pharmacists as the technology evolves.
Harini Bupathi, Esq, explains why pharmacies need to continue prioritizing PBM relationships despite rapid legislative change.
Researchers assessed the extent of which vaccine fatigue translates to reduced engagement and adherence among patients.
Brianne Porter, PharmD, MS, explores how pharmacists can deliver care to a population of women experiencing life-altering symptoms of urinary incontinence.
AJ Barbarito, Esq, explains how ERISA and Medicare Part D preemption limit state PBM laws and why a private right of action may be the most effective path forward.
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacist Roles, Risks in Guiding AI-Enabled Medical Device Use
2
Q&A: Why Enforcement Is the Weak Link in State PBM Reform | NCPA 2026
3
American Pharmacists Month: The Importance of Pharmacy-PBM Relationships
4
White House Declares Increased Focus on Women’s Health in US
5